JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M305399200 on May 29, 2003

J. Biol. Chem., Vol. 278, Issue 32, 29649-29654, August 8, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/32/29649    most recent
M305399200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prasad, R.
Right arrow Articles by Wilson, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prasad, R.
Right arrow Articles by Wilson, S. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Localization of the Deoxyribose Phosphate Lyase Active Site in Human DNA Polymerase {iota} by Controlled Proteolysis*

Rajendra Prasad {ddagger}, Katarzyna Bebenek {ddagger}, Esther Hou {ddagger}, David D. Shock {ddagger}, William A. Beard {ddagger}, Roger Woodgate §, Thomas A. Kunkel {ddagger} and Samuel H. Wilson {ddagger} ¶

From the {ddagger}Laboratory of Structural Biology, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709 and the §Section on DNA Replication, Repair, and Mutagenesis, NICHD, National Institutes of Health, Bethesda, Maryland 20892

Human DNA polymerase {iota} (pol {iota}) is a member of the Y-family of low fidelity lesion bypass DNA polymerases. In addition to a probable role in DNA lesion bypass, this enzyme has recently been shown to be required for somatic hypermutation in human B-cells. We found earlier that human pol {iota} has deoxyribose phosphate (dRP) lyase activity and unusual specificity for activity during DNA synthesis, suggesting involvement in specialized forms of base excision repair (BER). Here, mapping of the domain structure of human pol {iota} by controlled proteolysis revealed that the enzyme has a 48-kDa NH2-terminal domain and a protease resistant 40-kDa "core domain" spanning residues Met79 to ~Met445. A covalently cross-linked pol {iota}-DNA complex, representing a trapped intermediate in the dRP lyase reaction, was subjected to controlled proteolysis. Cross-linking was mapped to the 40-kDa core domain, indicating that the dRP lyase active site is in this region. To further evaluate the BER capacity of the enzyme, the dRP lyase and DNA polymerase activities were characterized on DNA substrates representing BER intermediates, and we found that pol {iota} was able to complement the in vitro single-nucleotide BER deficiency of a DNA polymerase {beta} null cell extract.


Received for publication, May 22, 2003

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: 111 T.W. Alexander Dr., P. O. Box 12233, MD B2-06, Research Triangle Park, NC 27709. Tel.: 919-541-3267; Fax: 919-541-3592; E-mail: wilson5{at}niehs.nih.gov.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
C. N. Kundu, R. Balusu, A. S. Jaiswal, and S. Narayan
Adenomatous polyposis coli-mediated hypersensitivity of mouse embryonic fibroblast cell lines to methylmethane sulfonate treatment: implication of base excision repair pathways
Carcinogenesis, October 1, 2007; 28(10): 2089 - 2095.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. N. Trivedi, K. H. Almeida, J. L. Fornsaglio, S. Schamus, and R. W. Sobol
The Role of Base Excision Repair in the Sensitivity and Resistance to Temozolomide-Mediated Cell Death
Cancer Res., July 15, 2005; 65(14): 6394 - 6400.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
L. Haracska, L. Prakash, and S. Prakash
A mechanism for the exclusion of low-fidelity human Y-family DNA polymerases from base excision repair
Genes & Dev., November 15, 2003; 17(22): 2777 - 2785.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.